These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 19415676

  • 1. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
    Yoshida T, Flegler A, Kozlov A, Stern PH.
    J Cell Biochem; 2009 Aug 01; 107(5):917-25. PubMed ID: 19415676
    [Abstract] [Full Text] [Related]

  • 2. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S, Liu XS, Huang S, Li Z, Pan H, Zhen W, Luk KD, Guo XE, Lu WW.
    Bone; 2011 Dec 01; 49(6):1290-8. PubMed ID: 21925296
    [Abstract] [Full Text] [Related]

  • 3. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Rédini F.
    Bone; 2007 Apr 01; 40(4):981-90. PubMed ID: 17196895
    [Abstract] [Full Text] [Related]

  • 4. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
    Ogawa N, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T.
    Horm Metab Res; 2007 Dec 01; 39(12):871-5. PubMed ID: 17960513
    [Abstract] [Full Text] [Related]

  • 5. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid.
    Takarada T, Hinoi E, Kambe Y, Sahara K, Kurokawa S, Takahata Y, Yoneda Y.
    Eur J Pharmacol; 2007 Dec 01; 575(1-3):1-11. PubMed ID: 17698058
    [Abstract] [Full Text] [Related]

  • 6. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
    Poulsen RC, Wolber FM, Moughan PJ, Kruger MC.
    Prostaglandins Other Lipid Mediat; 2008 Feb 01; 85(1-2):42-8. PubMed ID: 18077200
    [Abstract] [Full Text] [Related]

  • 7. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption.
    Stern PH, Alvares K.
    J Cell Biochem; 2014 Nov 01; 115(11):2033-8. PubMed ID: 25042887
    [Abstract] [Full Text] [Related]

  • 8. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M, Haag M, Kruger MC.
    J Nutr Biochem; 2007 Jan 01; 18(1):54-63. PubMed ID: 16650751
    [Abstract] [Full Text] [Related]

  • 9. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
    Ueno A, Miwa Y, Miyoshi K, Horiguchi T, Inoue H, Ruspita I, Abe K, Yamashita K, Hayashi E, Noma T.
    J Cell Physiol; 2006 Nov 01; 209(2):322-32. PubMed ID: 16883596
    [Abstract] [Full Text] [Related]

  • 10. Actions of fibroblast growth factor-8 in bone cells in vitro.
    Lin JM, Callon KE, Lin JS, Watson M, Empson V, Tong PC, Grey A, Naot D, Green CR, Reid IR, Cornish J.
    Am J Physiol Endocrinol Metab; 2009 Jul 01; 297(1):E142-50. PubMed ID: 19383871
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
    Bandyopadhyay S, Lion JM, Mentaverri R, Ricupero DA, Kamel S, Romero JR, Chattopadhyay N.
    Biochem Pharmacol; 2006 Jul 14; 72(2):184-97. PubMed ID: 16750176
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH.
    Biochem Pharmacol; 2007 Sep 15; 74(6):911-23. PubMed ID: 17662251
    [Abstract] [Full Text] [Related]

  • 13. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.
    Eur J Immunol; 2008 Jun 15; 38(6):1598-609. PubMed ID: 18421790
    [Abstract] [Full Text] [Related]

  • 14. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
    Uchiyama S, Yamaguchi M.
    J Cell Biochem; 2005 Aug 15; 95(6):1224-34. PubMed ID: 15962303
    [Abstract] [Full Text] [Related]

  • 15. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
    Jeong JC, Lee JW, Yoon CH, Kim HM, Kim CH.
    Toxicol In Vitro; 2004 Dec 15; 18(6):829-34. PubMed ID: 15465649
    [Abstract] [Full Text] [Related]

  • 16. Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells.
    Satué M, Arriero Mdel M, Monjo M, Ramis JM.
    Biochem Pharmacol; 2013 Nov 15; 86(10):1476-86. PubMed ID: 24060614
    [Abstract] [Full Text] [Related]

  • 17. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
    Kim JM, Min SK, Kim H, Kang HK, Jung SY, Lee SH, Choi Y, Roh S, Jeong D, Min BM.
    Int J Mol Med; 2007 Mar 15; 19(3):393-400. PubMed ID: 17273786
    [Abstract] [Full Text] [Related]

  • 18. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization of osteoblastic MC3T3-E1 cells.
    Kim KW, Suh SJ, Lee TK, Ha KT, Kim JK, Kim KH, Kim DI, Jeon JH, Moon TC, Kim CH.
    J Ethnopharmacol; 2008 Jan 04; 115(1):42-9. PubMed ID: 17997241
    [Abstract] [Full Text] [Related]

  • 19. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
    Sanuki R, Shionome C, Kuwabara A, Mitsui N, Koyama Y, Suzuki N, Zhang F, Shimizu N, Maeno M.
    Connect Tissue Res; 2010 Apr 04; 51(2):150-8. PubMed ID: 20001844
    [Abstract] [Full Text] [Related]

  • 20. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL, Kang SW, Kang MK, Gong JH, Lee ES, Han SJ, Kang YH.
    J Cell Biochem; 2012 Jan 04; 113(1):247-59. PubMed ID: 21898547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.